🔎 Trials Near Me

Home › Kanser sa Baga › Indiana › Indianapolis

Pag-aaral pangklinika para sa Kanser sa Baga sa Indianapolis, IN

16 pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Indianapolis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Nagre-recruitPhase 3
  • Saint Catherine Hospital, Indianapolis
Edad 70 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3
  • Saint Catherine Hospital, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Nagre-recruitPhase 3
  • Saint Catherine Hospital, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Nagre-recruitPhase 3
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
  • IU Health West Hospital, Avon · 13 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06498635

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Nagre-recruitPhase 1
  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • Community Health Network, Inc, Indianapolis
  • Community Health Network, Inc., Indianapolis
  • Community Health Network, Inc., Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Nagre-recruitPhase 2/3
  • Indiana University Health University Hospital, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • Community Health Network, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Increasing Equity in Lung Cancer Screening

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Eskenazi Health, Indianapolis
Edad 50 hanggang 80 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06360822

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • Community Cancer Center North, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Nagre-recruitObservasyonal na pag-aaral
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Roudebush VA Medical Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT05889546

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Nagre-recruitPhase 1/2
  • University of Indiana, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT06922591

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
18 Minutes · Lahat ng kasarian · Na-update May 5, 2026 · NCT06031688

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Nagre-recruitPhase 2
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 8, 2026 · NCT04919382

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Nagre-recruit
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT02984761

Pag-aaral para sa Kanser sa Baga sa ibang lungsod

Iba pang pag-aaral sa Indianapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.